MedTrace Logo

Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis

NCT04770857 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-07-29

No results posted yet for this study

Summary

Pancreatitis is the most common complication after ERCP, although its frequency varies significantly depending on the study from \< 2% up to 40%.

Based upon data from studies that have included unselected patients, post-ercp pancreatitis (PEP) is mild, moderate, and severe in 45%, 44%, and 11% of cases, respectively. Dysfunction of the sphincter Oddi, female gender, younger age, previous history of pancreatitis, prolonged procedure time and pancreatic guidewire passages are well-known independent risk factors for PEP.

This study will assess whether the development of PEP can be predicted by Visual analogue scale (VAS) level 1 hour after ERCP.

Conditions

  • Post-ERCP Acute Pancreatitis

Interventions

OTHER

Visual analogue scale

Post procedural pain assessment using the visual analogue scale (VAS) will be performed in patients undergoing ERCP

Sponsors & Collaborators

  • Nicola Frei

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-05-31
Completion
2023-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04770857 on ClinicalTrials.gov